home.social

#depressionresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #depressionresearch, aggregated by home.social.

  1. DATE: May 28, 2026 at 12:42AM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: New depression treatment targets the immune system instead of the brain

    URL: sciencedaily.com/releases/2026

    A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression

  2. DATE: May 28, 2026 at 12:42AM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: New depression treatment targets the immune system instead of the brain

    URL: sciencedaily.com/releases/2026

    A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression

  3. DATE: May 28, 2026 at 12:42AM
    SOURCE: SCIENCE DAILY PSYCHIATIRY FEED

    TITLE: New depression treatment targets the immune system instead of the brain

    URL: sciencedaily.com/releases/2026

    A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #DepressionTreatment #Immunotherapy #AntiInflammatory #MentalHealthNews #DepressionResearch #BrainImmuneConnection #InflammationAndMood #ClinicalTrial #MentalWellness #HardToTreatDepression

  4. 🧠 Could gut metabolites hold the key to enhancing antidepressant effects?

    🔗 Does isovaleric acid play a key role in the interaction between probiotics and antidepressants? A secondary analysis of a randomized clinical trial. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.05

    📚 CSBJ: csbj.org/

    #GutBrainAxis #MentalHealth #Probiotics #DepressionResearch #Psychobiotics #Microbiome

  5. Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.

    This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.

    #ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch

  6. Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.

    This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.

    #ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch

  7. Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.

    This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.

    #ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch

  8. Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.

    This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.

    #ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch

  9. Our study explores innovative strategies to prolong the antisuicidal effects of ketamine in individuals with treatment-resistant depression, a critical step toward improving outcomes for patients in crisis.

    This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality.

    #ADAA2025 #SuicidePrevention #DepressionResearch #CareerDevelopment #ClinicalTrials #MentalHealthResearch

  10. 🧠 Breakthrough in depression research! 🔬 Stanford Medicine identifies 6 distinct depression "biotypes" using fMRI & machine learning. This could revolutionize treatment by predicting responses based on brain patterns. A step towards personalized mental health care! 🎯💊

    #DepressionResearch #MentalHealth #PrecisionMedicine

    med.stanford.edu/news/all-news